Home › Companies › OCUGEN INC. › 2023-2024
At OCUGEN INC.'s shareholder meeting held June 28, 2024, in the 2023-2024 proxy season, 64 asset managers reported how they voted in their SEC Form N-PX filings, covering 222 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. OCUGEN INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval, on an advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. — the reporting funds and managers cast 99.9% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and OCUGEN INC.’s Form 8-K, filed June 28, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 28, 2024: 7 items on OCUGEN INC.’s Form 8-K, filed June 28, 2024: 2 elected · 3 approved · 2 not approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore OCUGEN INC. in the interactive database Compare manager voting policies
These tallies are OCUGEN INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 28, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Shankar Musunuri, Ph. D., MBA | 55,840,122 | -- | -- | 5,447,583 | 46,450,503 | 91% | Elected | — |
| Elect Director: Junge Zhang, Ph. D. | 54,459,369 | -- | -- | 6,828,336 | 46,450,503 | 89% | Elected | — |
| (b) Proposal 2 - Ratification of Independent Registered Public Accountant . The Company withdrew the proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2024 fiscal | 48,751,037 | 10,722,166 | 1,814,502 | -- | 46,450,503 | 82% | Approved | — |
| 4. Approval of an amendment to the Company's charter to limit the liability of certain officers of the Company as permitted by recent amendments to the Delaware General Corporation Law (the 'DGCL") | 49,000,962 | 10,333,187 | 1,953,556 | -- | 46,450,503 | 83% | Not approved A stricter vote than a majority of the votes cast may have applied to this item; the filing does not state it. | — |
| 5. Approval of an amendment to the Company's charter to increase the number of authorized shares of Common Stock | 80,474,755,361 | 25,535,231,721 | 1,835,959,126 | -- | 0 | 76% | Approved | — |
| 6. Approval of an amendment to the Company's charter to adjust voting requirements for certain future amendments to the Company's charter in accordance with recent amendments to Section 242(d) of the DGCL | 48,904,416,560 | 10,061,624,573 | 2,382,951,572 | -- | 46,496,953,503 | 83% | Not approved A stricter vote than a majority of the votes cast may have applied to this item; the filing does not state it. | — |
| 7. Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve all proceeding | 87,974,708 | 17,570,043 | 2,193,457 | -- | 0 | 83% | Approved | — |
Source: OCUGEN INC., Form 8-K, filed with the SEC on June 28, 2024 — read the filing on EDGAR.
Each item below shows how the 64 asset managers that disclosed a OCUGEN INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of OCUGEN INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Description as filed by funds: The election of Class I Directors for a Three-Year Term Expiring in 2027: Junge Zhang, Ph.D.
OCUGEN INC.’s own tally for this item (“Elect Director: Junge Zhang, Ph. D.”): 54,459,369 for, 6,828,336 withheld, per its Form 8-K filed June 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected each director nominee to the Board of Directors to serve as a director until the 2027 Annual Meeting of Stockholders and until their respective successor, if any, is elected or appointed, or upon their earlier death, resignation, retirement, disqualification, or removal, as…”
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 793,769 | 0 | 0 | 0 | For |
| BlackRock | 344,034 | 0 | 0 | 0 | For |
| Fidelity | 81,561 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 11,216 | Withhold |
| Charles Schwab | 8,554 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 0 | 2,201 | Withhold |
| Amplify ETF Trust | 1,860 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 156 | 0 | Abstain |
| Nationwide | 0 | 0 | 0 | 100 | Withhold |
Fund voting reports, all 9 managers: 1,229,778 for, 13,517 withheld, 156 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 500,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 500,000 for.
Combines 2 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: The election of Class I Directors for a Three-Year Term Expiring in 2027: Shankar Musunuri, Ph.D., MBA
OCUGEN INC.’s own tally for this item (“Elect Director: Shankar Musunuri, Ph. D., MBA”): 55,840,122 for, 5,447,583 withheld, per its Form 8-K filed June 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected each director nominee to the Board of Directors to serve as a director until the 2027 Annual Meeting of Stockholders and until their respective successor, if any, is elected or appointed, or upon their earlier death, resignation, retirement, disqualification, or removal, as…”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 9 asset managers below reported 1,243,451 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 793,769 | 0 | 0 | 0 | For |
| BlackRock | 344,034 | 0 | 0 | 0 | For |
| Fidelity | 81,561 | 0 | 0 | 0 | For |
| American Century | 11,216 | 0 | 0 | 0 | For |
| Charles Schwab | 8,554 | 0 | 0 | 0 | For |
| Guggenheim | 2,201 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 1,860 | 0 | 0 | 0 | For |
| John Hancock | 156 | 0 | 0 | 0 | For |
| Nationwide | 100 | 0 | 0 | 0 | For |
Combines 3 wordings of this item as funds reported it.
83% Not approved · of votes cast
Description as filed by funds: Approval of an amendment to Ocugen, Inc.'s Charter to adjust voting requirements for certain future amendments to Ocugen, Inc.'s Charter in accordance with recent amendments to Section 242(d) of the DGCL.
OCUGEN INC.’s own tally for this item (“6. Approval of an amendment to the Company's charter to adjust voting requirements for certain future amendments to the Company's charter in accordance with recent amendments to Section 242(d) of the DGCL”): 48,904,416,560 for, 10,061,624,573 against — failed, per its Form 8-K filed June 28, 2024 (Item 5.07). This item required more than a simple majority of votes cast — see the filing.
Reported outcome: Not approved, in the filing’s own words: “The stockholders did not approve this proposal.”
A stricter vote than a majority of the votes cast may have applied to this item; the filing does not state it.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 793,769 | 0 | 0 | 0 | For |
| BlackRock | 344,034 | 0 | 0 | 0 | For |
| Fidelity | 81,561 | 0 | 0 | 0 | For |
| American Century | 11,216 | 0 | 0 | 0 | For |
| Charles Schwab | 8,554 | 0 | 0 | 0 | For |
| Guggenheim | 2,201 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 1,860 | 0 | 0 | 0 | For |
| John Hancock | 156 | 0 | 0 | 0 | For |
| Nationwide | 100 | 0 | 0 | 0 | For |
Fund voting reports, all 9 managers: 1,243,451 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 875,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 875,000 for.
Combines 3 wordings of this item as funds reported it.
83% Not approved · of votes cast
Description as filed by funds: Approval of an amendment to Ocugen, Inc.'s Sixth Amended and Restated Certificate of Incorporation, as amended (the "Charter") to limit the liability of certain officers of Ocugen, Inc. as permitted by recent amendments to the Delaware General Corporation Law ("DGCL").
OCUGEN INC.’s own tally for this item (“4. Approval of an amendment to the Company's charter to limit the liability of certain officers of the Company as permitted by recent amendments to the Delaware General Corporation Law (the 'DGCL")”): 49,000,962 for, 10,333,187 against — failed, per its Form 8-K filed June 28, 2024 (Item 5.07). This item required more than a simple majority of votes cast — see the filing.
Reported outcome: Not approved, in the filing’s own words: “The stockholders did not approve this proposal.”
A stricter vote than a majority of the votes cast may have applied to this item; the filing does not state it.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 793,769 | 0 | 0 | 0 | For |
| BlackRock | 344,034 | 0 | 0 | 0 | For |
| Fidelity | 81,561 | 0 | 0 | 0 | For |
| American Century | 11,216 | 0 | 0 | 0 | For |
| Charles Schwab | 8,554 | 0 | 0 | 0 | For |
| Guggenheim | 2,201 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 1,860 | 0 | 0 | 0 | For |
| John Hancock | 156 | 0 | 0 | 0 | For |
| Nationwide | 100 | 0 | 0 | 0 | For |
Fund voting reports, all 9 managers: 1,243,451 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 875,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 875,000 for.
Combines 2 wordings of this item as funds reported it.
76% Approved · of votes cast
Description as filed by funds: Approval of an amendment to our Charter to increase the number of authorized shares of common stock from 295,000,000 to 390,000,000.
OCUGEN INC.’s own tally for this item (“5. Approval of an amendment to the Company's charter to increase the number of authorized shares of Common Stock”): 80,474,755,361 for, 25,535,231,721 against — passed, per its Form 8-K filed June 28, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved this proposal.”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 793,769 | 0 | 0 | 0 | For |
| BlackRock | 344,034 | 0 | 0 | 0 | For |
| Fidelity | 81,561 | 0 | 0 | 0 | For |
| American Century | 11,216 | 0 | 0 | 0 | For |
| Charles Schwab | 8,554 | 0 | 0 | 0 | For |
| Guggenheim | 2,201 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 1,860 | 0 | 0 | 0 | For |
| John Hancock | 156 | 0 | 0 | 0 | For |
| Nationwide | 100 | 0 | 0 | 0 | For |
Fund voting reports, all 9 managers: 1,243,451 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 875,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 875,000 for.
Combines 2 wordings of this item as funds reported it.
83% Approved · of votes cast
Description as filed by funds: Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 1 - 6.
OCUGEN INC.’s own tally for this item (“7. Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve all proceeding”): 87,974,708 for, 17,570,043 against — passed, per its Form 8-K filed June 28, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 7: Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve all proceeding , as follows:”
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 793,769 | 0 | 0 | 0 | For |
| BlackRock | 344,034 | 0 | 0 | 0 | For |
| Fidelity | 81,561 | 0 | 0 | 0 | For |
| American Century | 0 | 11,216 | 0 | 0 | Against |
| Charles Schwab | 8,554 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 2,201 | 0 | 0 | Against |
| Amplify ETF Trust | 1,860 | 0 | 0 | 0 | For |
| John Hancock | 0 | 156 | 0 | 0 | Against |
| Nationwide | 0 | 100 | 0 | 0 | Against |
Fund voting reports, all 9 managers: 1,229,778 for, 13,673 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 875,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 875,000 for.
100% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 0 | 0 | 8,554 | 0 | Abstain |
| Amplify ETF Trust | 1,860 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 156 | 0 | Abstain |
Fund voting reports, all 3 managers: 1,860 for, 8,710 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 375,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 375,000 for.
Combines 4 wordings of this item as funds reported it.
99.9% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 793,769 | 0 | 0 | 0 | For |
| BlackRock | 344,034 | 0 | 0 | 0 | For |
| Fidelity | 81,561 | 0 | 0 | 0 | For |
| American Century | 11,216 | 0 | 0 | 0 | For |
| Charles Schwab | 8,554 | 0 | 0 | 0 | For |
| Guggenheim | 2,201 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 1,860 | 0 | 0 | 0 | For |
| John Hancock | 156 | 0 | 0 | 0 | For |
| Nationwide | 100 | 0 | 0 | 0 | For |
Fund voting reports, all 9 managers: 1,243,451 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 1,219,900 | 0 | 0 | 0 | For |
| BlackRock | 1,138,176 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 723,752 | 0 | 0 | 0 | For |
| Two Sigma | 657,356 | 0 | 0 | 0 | For |
| Northern Trust | 442,475 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 375,000 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 240,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 187,100 | 0 | 0 | 0 | For |
| Point72 | 165,282 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 89,988 | 0 | 0 | 0 | For |
| State Street | 75,626 | 0 | 0 | 0 | For |
| CAPTRUST FINANCIAL ADVISORS | 60,001 | 0 | 0 | 0 | For |
| Fidelity | 28,811 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 14,228 | 0 | 0 | 0 | For |
| BLAIR WILLIAM & CO/IL | 12,954 | 0 | 0 | 0 | For |
| American Century | 11,216 | 0 | 0 | 0 | For |
| Lanham O'Dell & Company, Inc. | 10,050 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 10,000 | 0 | 0 | 0 | For |
| Charles Schwab | 9,004 | 0 | 0 | 0 | For |
| Mill Capital Management, LLC | 9,000 | 0 | 0 | 0 | For |
| Prudential/PGIM | 8,300 | 0 | 0 | 0 | For |
| TRUIST FINANCIAL CORP | 8,107 | 0 | 0 | 0 | For |
| Fisher Asset Management, LLC | 5,585 | 0 | 0 | 0 | For |
| Vanguard | 5,449 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 4,982 | 0 | 0 | 0 | For |
Institutional-manager reports, all 59 managers: 5,548,040 for, 237 against. Showing the 25 largest; every one is in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of June 5, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 257,328,085 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 0.31% |
| 2 | BlackRock | 0.13% |
| 3 | Fidelity | 0.03% |
| 4 | American Century | <0.01% |
| 5 | Charles Schwab | <0.01% |
| 6 | Guggenheim | <0.01% |
| 7 | Amplify ETF Trust | <0.01% |
| 8 | John Hancock | <0.01% |
| 9 | Nationwide | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BALYASNY ASSET MANAGEMENT L.P. | 0.47% |
| 2 | BlackRock | 0.44% |
| 3 | MARSHALL WACE, LLP | 0.28% |
| 4 | Two Sigma | 0.26% |
| 5 | Northern Trust | 0.17% |
| 6 | Altium Capital Management LP | 0.15% |
| 7 | PNC BANK, NATIONAL ASSOCIATION | 0.09% |
| 8 | T. Rowe Price | 0.07% |
| 9 | Point72 | 0.06% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 0.03% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 5.92% | 13F |
| Shankar Musunuri, Ph. D., MBA | 2.49% | DEF14A |
| BlackRock | 1.58% | 13F |
| Geode Capital | 1.25% | 13F |
| Millennium Management | 0.75% | 13F |
| Junge Zhang, Ph. D. | 0.59% | DEF14A |
| Uday B. Kompella, Ph. D. | 0.43% | DEF14A |
| Two Sigma | 0.40% | 13F |
| State Street | 0.37% | 13F |
| Arun Upadhyay, Ph. D. | 0.28% | DEF14A |
Percentages above are of 257,328,085 shares outstanding, as reported by OCUGEN INC. on its Form 10-Q dated May 7, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from OCUGEN INC.’s 10-Q dated May 7, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
OCUGEN INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “OCUGEN (OCGN) 2024 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/ocugen-inc/2024 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.